LAREGAB AT

About

LAREGAB AT combines Pregabalin and Amitriptyline, providing a comprehensive approach to managing neuropathic pain and associated conditions. Pregabalin, an alpha-2-delta ligand, reduces neuronal hyperexcitability by modulating excitatory neurotransmitter release, thereby alleviating nerve pain. Amitriptyline, a tricyclic antidepressant (TCA), works by inhibiting the reuptake of norepinephrine and serotonin in the brain, increasing their concentrations in the synaptic cleft. This dual action contributes to its antidepressant effects and its efficacy in treating neuropathic pain, chronic tension headaches, and migraine prophylaxis. The combination offers synergistic pain relief, particularly beneficial for patients experiencing severe or refractory neuropathic pain often accompanied by mood disturbances, anxiety, or sleep issues. By targeting different pain pathways and neurotransmitter systems, this formulation aims to provide enhanced therapeutic outcomes and improve overall patient well-being.

Uses

• Management of chronic neuropathic pain
• Treatment of pain associated with depression
• Relief from postherpetic neuralgia
• Prophylaxis of chronic tension headaches and migraines

Directions For Use

Take orally as directed by your physician, usually once daily, preferably at bedtime. Do not stop abruptly without medical advice.

Benefits

• Provides synergistic relief for complex neuropathic pain
• Addresses both nerve pain and associated mood disturbances
• Improves sleep quality in patients with chronic pain
• Offers a comprehensive approach to pain management
• Reduces the need for higher doses of individual components
• Effective in conditions like diabetic neuropathy and postherpetic neuralgia

Side Effects

• Dizziness
• Drowsiness
• Dry mouth
• Constipation
• Blurred vision
• Weight gain
• Urinary retention
• Orthostatic hypotension
• Tachycardia
• Nausea
• Headache
• Difficulty concentrating

Safety Measures

• Alcohol - Avoid alcohol; it can enhance CNS depression and increase the risk of adverse effects.
• Pregnancy - Use with caution; potential risks to the fetus exist. Discuss with a doctor to weigh benefits against risks.
• Breastfeeding - Not recommended due to excretion in breast milk and potential for infant sedation or other adverse effects.
• Liver - Use with caution in hepatic impairment; dose adjustment may be necessary, especially for amitriptyline.
• Kidney - Requires dose adjustment for pregabalin in renal impairment. Amitriptyline is primarily metabolized by the liver.
• Lung - Use with caution in patients with respiratory depression, especially with other CNS depressants.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.